Tharimmune, Inc. THAR
Set alert
As of Apr 22, 12:59 PM ET
- YTD
- +16.83%
- 1 year
- +207.83%
- Open
- 3.34
- Prev close
- 3.54
- Mkt cap
- 3.11M
- Vol
- 358.85K
- Avg vol
- 1.26M
- EPS
- 61.01
- P/E
- 0.03
- Div yield
- 0.00%
More statistics
- Low
- 3.32
- High
- 3.58
- Forward P/E
- -17.42
- Beta
- 1.45
- Short ratio
- 0.02
- Inst. own
- 1.63%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 21, 2024
- 50-d avg
- 2.29
- 200-d avg
- 3.71
- 1y target
- 0.00
Discussion (7)
Sign in to join the discussion
George Miller THAR 12 months ago #1$THAR Market cap still at $400 M after 80% pop. This should trade above $2-5 billions range like other mineral stocks . Expect to run this stock throughput the week and make massive profits.
No pressure - just thought you might find the introduction useful
Text&Wassup+44/ 7/4/4/6/0/6/6/2/9/5
ApexTradez.com THAR 1 year ago #2It will SQUEEZE hard next week Shorts playing with fire
Wael Jawa THAR 2 years ago #3$MKTW !!!!!
VICKY HANUKA THAR 2 years ago #50.158
0.260
-2.05%
+64.74%
Post
The company expects completion and topline data of a Phase 2 clinical trial in chronic pruritis over approximately 12 months after aligning with FDA on trial design.
VICKY HANUKA THAR 2 years ago #605%
+64.74%
Post
This announcement includes 4 separate documents：
Doc 1： View Original
Doc 2： View Original
Doc 3： View Original
Doc 4： View Original
This
VICKY HANUKA THAR 2 years ago #7Tharimmune Enters Exclusive Global Licensing Agreement For Clinical Stage Asset For Chronic Pruritis